List Title | APhA DrugInfoLine

Rheumatology

SORT BY: Most Recent Most Viewed

December 18, 2018

Steroid injection an ideal option for first-time carpal tunnel syndrome

READ

PREVIEW
For patients with mild or moderate carpal tunnel syndrome, a single local corticosteroid injection was superior to a night-resting splint for rapid and sustained symptom improvement, according to...
December 11, 2018

Aspirin may be good for knee replacement thromboembolism prevention

READ

PREVIEW
Use of aspirin prophylaxis for patients undergoing a total knee arthroplasty (TKA) to prevent venous thromboembolism (VTE) was noninferior to other anticoagulant chemoprophylactic regimens....
August 21, 2018

I.M. glucocorticoids may be an option for painful hip osteoarthritis

READ

PREVIEW
A small exploratory study showed that an I.M. injection of triamcinolone acetate into the gluteus muscle for patients with painful hip osteoarthritis improved pain at rest and during activity over...
May 29, 2018

Alternative treatment may be an option for patients with RA

READ

PREVIEW
Use of resveratrol as an adjunct therapy to conventional treatments in patients with rheumatoid arthritis (RA) resulted in a significant decrease in major clinical and biochemical markers of...
May 21, 2018

Temporary stopping MTX improves immunogenicity of influenza vaccination

READ

PREVIEW
In patients with rheumatoid arthritis (RA), holding the methotrexate (MTX) dose for 2 weeks after administration of the seasonal influenza vaccine improved vaccine response compared with patients...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.